1. Lobana T., Sharma R., Bawa G., Khanna S.(2009). Bonding and structure trends of thiosemicarbazone derivatives of metals—An overview. Coordination Chemistry Review, 253:977-1055.
2. Momeni Z., Shahbazi, S., Khavasi, R.(2010). Polyhedron, 29: 1393.
3. Wiecek, J.; Dokorou, V.; Zbigniew, C.; KovalaDemertzi, D.(200) Polyhedron, 28: 3298.
4. Suni, V., Prathapachandra R., Nethaji M. (2007). Polyhedron, 26: 5203.
5. Gazieva G. Thiosemicarbazides in the synthesis of five- and six-membered heterocyclic compounds.(2012). Russian Chemical Reviews, 81(6):494-523.
6. Hadi A., Jawad Kh., Ahmed D., Yousif E.(2019). Synthesis and Biological Activities of Organotin (IV) Carboxylates: A Review. Sys Rev Pharm, 10(1):26-31.
7. Affan M., Salam M., Ahmed F., Ismail J., Shamsuddin M., Ali H.(2011). Synthesis and spectroscopic characterization of organotin(IV) complexes with 2-benzoylpyridine-N(4)-cyclohexylthiosemicarbazone (HBPCT): X-ray crystal structure of [PhSnCl2(BPCT)]. Inorganica Chimica Acta, 366:227-232.
8. Affan M., Salam M., Saha R., Ahmed F., Sam N.(2012). Synthesis, Characterization and In Vitro Antibacterial Studies of Organotin(IV) Complexes with 2-Hydroxyacetophenone-2-methylphenylthiosemicarbazone (H₂dampt). Bioinorganic Chemistry and Applications, 698491.
9. Haque R., Salam M., Arafath MD.(2015) New organotin(IV) complexes with N(4)-methylthiosemicarbazone derivatives prepared from 2,3-dihydroxybenzaldehyde and 2-hydroxy-5-methylbenzaldehyde: synthesis, characterization, and cytotoxic activity. Journal of Coordination Chemistry, 68(16): 2953-2967.

10. Wiecek J., Dokorou V., Ciunik Z., Kovala-Demertzi D.(2009). Organotin complexes of pyruvic acid thiosemicarbazone: Synthesis, crystalstructures and antiproliferative activity of neutral and cationic diorganotin complexes. Polyhedron, 28: 3298–3304.

11. Haque R., Salam M.(2015). Synthesis, spectroscopic properties and biological activity of new mono organotin(IV) complexes with 5-bromo-2-hydroxybenzaldehyde-4,4-dimethylthiosemicarbazone. Cogent Chemistry, 1:1045212.

1. 12.  Huedo C., Zania F., Mendiola A., Pradhan S., Sinha Ch., Lopez-Torres E.(2018). Synthesis, antimicrobial activity and molecular docking of di‐ and triorganotin (IV) complexes with thiosemicarbazide derivatives. Appl Organometal Chem,:e4700.
2. 13.  Singh H., Singh J., Bhanuka S.(2016). Synthesis, spectroscopic characterization, biological screening, and theoretical studies of organotin(IV) complexes of semicarbazone and thiosemicarbazones derived from (2-hydroxyphenyl) (pyrrolidin-1-yl)methanone. Research on Chemical Intermediates, 42:997-1015.
3. 14.  Mendes I., Moreira J., Ardisson J., Santos R.,
   O. da Silva P., Garcia I., Castineiras A., Beraldo H.(2008). Organotin(IV) complexes of 2-pyridineformamide-derived thiosemicarbazones: Antimicrobial and cytotoxic effects. European Journal of Medicinal Chemistry, 43:1454-1461.
4. 15.  Singh M., Singh P.(2003). Highly Versatile Synthesis of Some Organotin(IV) Complexes of 2-ydroxyacetophenone Semicarbazone and Thiosemicarbazone. Synthesis and reactivity in inorganic and metal organic chemistry, 33(10): 1895–1909.

16. Khan Md., Salam Md., Haque R., Abdul Majid A., Bin Abdul Majid A., Asif M., Basheer M., and Tabana Y.(2016). Synthesis, cytotoxicity, and long-term single dose
anti-cancer pharmacological evaluation of dimethyltin(IV) complex of N(4)-methylthiosemicarbazone (having ONS donor ligand). Cogent Biology, 2, 1154282.

17. Go R., Adjei A.(1999). Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin. Journal of Clinical Oncology, 17(1), 409-422.

18. Zhang C., Lippard S.(2003). New metal complexes as potential therapeutics. Curr. Opin. Chem. Biol., 7:481-489.

1. 19.  Zeglis B.M., Pierre V.C., Barton J.K..(2007). Metallo-intercalators and metallo-insertors, Chem. Commun, 4565-4579.

20. Adeyemi J., Onwudiwe D.(2018). Organotin(IV) Dithiocarbamate Complexes: Chemistry and Biological Activity. Molecules, 23: 2571.

21. Khandani M., Sedaghat T., Erfani N., Haghshenas M.,  Khavasi H.(2013). Synthesis, spectroscopic characterization, structural studies and antibacterial and antitumor activities of diorganotin complexes with
3-methoxysalicylaldehyde thiosemicarbazone. Journal of Molecular Structure, 1037, 136–143.

1. 22.  Ullah H., Previtali V., Mihigo H., Twamley B., Rauf M., Javed F., Waseem A.(2019). BakerR., Rozas I. Structure-activity relationships of new Organotin(IV) anticancer agents and their cytotoxicity profile on HL-60, MCF-7 and HeLa human cancer cell lines. European Journal of Medicinal Chemistry, 181, 111544.
2. 23.  Kamaludin N., Awang N., Baba I. Hamid A., Meng Ch.(2013). Synthesis, Characterization and Crystal Structure of Organotin(IV) N-Butyl-N-phenyldithiocarbamate Compounds and their Cytotoxicity in Human Lukemia Cell Lines. Pakistan Journal of Biological Sciences, 16(1), 12-21.
3. 24.  Ahmad M., Hussain M., Hanif M., Ali S.,  Mirza B.(2007). Synthesis, Chemical Characterization and Biological Screening
   for Cytotoxicity and Antitumor Activity of Organotin (IV) Derivatives of 3,4-Methylenedioxy 6-nitrophenylpropenoic Acid. Molecules, 12, 2348-2363.
4. 25.  Rocamora-Reverte L., Carrasco-Garca E., Ceballos-Torres J., Prashar S., Kalud¯erovic´ G., Ferragut J., Gomez-Ruiz S.(2012). Study of the Anticancer Properties of Tin(IV) Carboxylate
   Complexes on a Panel of Human Tumor Cell Lines. ChemMedChem., 7, 301 – 310.
5. 26.  Awang N., Baba I., Yamin B., Othman M., Kamaludin N.(2011). Synthesis, Characterization and Biological Activities of Organotin (IV)
   Methylcyclohexyldithiocarbamate Compounds. American Journal of Applied Sciences, 8(4): 310-317.
6. 27.  Salam M., Hussein M., Ramli I., Saiful-Islam Md.(2016). Organomet J. Synthesis, structural characterization, and evaluation of biological
   activity of organotin(IV) complexes with 2-hydroxy-5-methoxybenzaldehyde-N(4)-methylthiosemicarbazone. Chem, 813, 71–77.
7. 28.  Khandani M., Sedaghat T., Erfani N., Haghshenas M., Khavasi H.(2013). J. Mol. Struct.. 1037, 136–143.
8. 29.  Narayanan, V.L.; in Reinhoudt, D.N.; Connors, T.A.; Pinedo, H.M.; van de Poll, K.W.(1983).(Eds.). Structure-activity relationship of anti-tumour agents, Martinus Nijhoff. The Hague, 5.
9. 30.  Affan M., Salam M., Saha R., Ahmed F., White F., Ali H.(2012). Organotin(IV) complexes of 2-hydroxyacetophenone-N(4)-cyclohexylthiosemicarbazone (H2dact): Synthesis, spectral characterization, crystal structure
   and biological studies. Inorganica Chimica Acta., 387, 219–225.
10. 31.  Bonaccorso C., Marzo T., Mendola D.(2020). Biological Applications of Thiocarbohydrazones and
    Their Metal Complexes: A Perspective Review. Pharmaceuticals, 13(4).
11. 32.  Iftikhar S., Gilani S., Taj M., Raheel A., Din I., Termizi S., Al-Shakban M., Ali H.(2018). Design, synthesis and biological evaluation of organotin(IV)
    complexes of flumequine and cetirizine. Journal of the Serbian Chemical Society. 2018, 8 (4), 425–437.
12. 33.  Hadjikakou S.K., Hadjiliadis N.(2009). Coord. Chem. Rev., 253: 235.
13. 34.  Pettinari C., Marchetti F., Pettinari R., Cingolani A., Drozdov A., Troyanov S.(2002). Dalton Trans, 188–194.
14. 35.  Prasad K., Kumar L., Shekar S., Prasad M., Revanasiddappa H.(2001). Chem. Sci. J., 12 , 1-10.
15. 36.  Arjmand F., Parveen S., Tabassum S., Pettinari C.(2014). Organo-tin antitumor compounds: Their present status in drug development and future perspectives. Inorganica Chimica Acta., 423(B), 26-37.
16. 37.  Gielen M., Coord. Chem. Rev. 1996;151: 41.
17. 38.  Gielen M., J. Braz. Chem. Soc. 2003;14: 870.
18. 39.  Devi J., Yadaf. (2018). J. Recent Advancements in Organotin(IV) Complexes as Potential Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry, 18, 335-353.
19. 40.  Saxena A.(1989). Organotin(IV) compounds and cancer chemotherapy. Coordination Chemistry Reviews, 95, 109-123.
20. 41.  Storr, T.; Thompson, K.H.; Orvig, C.(2006). Design of targeting ligands in medicinal inorganic chemistry. Chem. Soc. Rev., 35(6), 534- 544.
21. 42.  Keppler, B.K.(2008). Carbohydrate-metal complexes and their potential as anticancer agents. Curr. Med. Chem., 15(25), 2574–2591.
22. 43.  Cortes L., Okio C., Brandao P.(2011). Tin(IV) Complexes of 1,5-phenylthiosemicarbazone and thiosemicarbazide: Synthesis, X-ray Characterization and Biological Activity. Phosphorus, Sulfur, and Silicon, 186, 1356–1360.
23. 44.  Van der K, Luijten JGA.(1954). Investigations on organo-tin compounds. III. The biocidal properties of organo-tin compounds. J App Chem., 4(6), 314-9.
24. 45.  Van der KGJM, Luitjten JGA.(1956). Investigations on organo-tin compounds. V The preparation and antifungal properties of unsymmetrical tri-n-alkyltin acetates. J. App Chem., 6(2), 56-60.

46. Saxena A., Tandon J.P.(1983). Polyhedron., 2, 443–446.

1. 47.  Singh H., Singh J., Sharma K.(2012). Synthetic, structural, and antimicrobial studies of organotin(IV) complexes of semicarbazone, thiosemicarbazone derived from 4-hydroxy-3-methoxybenzaldehyde. Res Chem Intermed., 38, 53–65.
2. 48.  Zafarian H., a, Sedaghat T., Motamedi H., Rudbari H.(2016). A multiprotic ditopic thiocarbohydrazone ligand in the formation of mono-and di-nuclear organotin(IV) complexes: Crystal structure, antibacterial activity and DNA cleavage. Journal of Organometallic Chemistry., 825-826, 25-32.
3. 49.  Salam M., Affan M., Arafat Md., Saha R., Nasrin R.(2013). Synthesis, Characterization, and Antibacterial Activities of Organotin(IV) Complexes with 2-Acetylpyridine-N(4) cyclohexylthiosemicarbazone (HAPCT). Heteroatom Chemistry., 24(1).
4. 50.  Siang-Guan Teoh S.,*,a Show-Hing Ang,a Soon-Beng Teo,a Hoong-Kun Fun,b Khing-Ling Khew c.,Chi-Wi Ong.(1997). Synthesis, crystal structure and biological activity of bis(acetone thiosemicarbazone-S)dichlorodiphenyltin(IV). J. Chem. Soc., Dalton Trans, 465–468.
5. 51.  López-Torres E., Zani F., Mendiola M.(2011). Antimicrobial activity of organotin(IV) complexes with the ligand benzil bis(benzoylhydrazone) and 4,4′-bipyridyl as coligand. Journal of Inorganic Biochemistry, 105, 600–608.
6. 52.  Singh H., Varshney A.(2006). Synthetic, Structural, and Biochemical Studies of Organotin(IV) With Schiff Bases Having Nitrogen and Sulphur Donor Ligands. Bioinorganic Chemistry and Applications., Article ID 23245: 1–7.
7. 53.  Singh H., Gupta M., Varshney A.(2001). Organotin(IV) complexes of Schiff bases derived by condensation of heterocyclic ketones and sulfa drugs. Res. Chem. Intermed, 27(6), 605–614.
8. 54.  Awang N., Zakri N., Zain N.(2016). Antimicrobial activity of organotin(IV) alkylisopropildithiocarbamate compounds. J. Chem. Pharm. Res., 8(3), 862-866.
9. 55.  Zhang X., Yan H., Song Q., Liu X., Tang L.(2007). Synthesis, structure and biological activity of organotin derivatives with pyridylmethylthiobenzoic acid, Polyhedron, 26, 3743–3749.
10. 56.  Rehman W., Badshah A., Khan S., Tuyet L.(2009). Synthesis, characterization, antimicrobial and antitumor screening of some diorganotin(IV) complexes of 2-[(9H-purin-6-ylimino)]-phenol, Eur. J. Med. Chem., 44, 3981–3985.
11. 57.  Rehman W., Baloch M., Badshah A., Ali S.(2006) Synthesis, characterization and biological study of diorganotin(IV) complexes of monomethyl phthalate, Spectrochim. Acta A., 65, 689–694.
12. 58.  Rehman W., Baloch M., Badshah A.(2008). Synthesis, spectral characterization and bio-analysis of some organotin(IV) complexes, Eur. J. Med. Chem., 43, 2380–2385
13. 59.   Yeaman R., Yount N.(2003). Mechanisms of antimicrobial peptide action and resistance, Pharmacol. Rev., 55, 27–55.

60. Tenover F.(2006). Mechanisms of antimicrobial resistance in bacteria, Am. J. Med., 119, 62–70.

1. 61.  Hawkey P., Lewis D.(1994). Medical Bacteriology—A Practical Approach, Oxford University Press, Oxford.